Cat Wong

With AWS, genomics customers can dedicate more time and resources to science, speeding time to insights, achieving breakthrough research faster, and bringing lifesaving products to market.

Watch a step-by-step guide for the Biotech Blueprint Quick Starts, which help you build a preclinical, cloud-based infrastructure on the AWS Cloud, based on industry best practices.

This Quick Start deploys a model environment that can help organizations with workloads that fall within the scope of the U.S. Health Insurance Portability and Accountability Act (HIPAA).

Learn how healthcare and life sciences startups leverage AWS to transform the world of health and accelerate research.

Learn about the tools that are available to make sense of large pools of data for Life Science organizations.

This session focuses on the two core challenges in developing and maintaining complex bioinformatics workloads: Containerization and Orchestration.

Learn about the native AWS tools that help users build out secure and flexible environments, with practices that are important specifically to life sciences companies.

Read about the Installation Qualification (IQ), a proposed approach that can automate one of the first components of a validation plan.

Providing specific solutions to meet the low-latency, local data processing, and data residency needs of healthcare and life sciences organizations using AWS Outposts.

In this guide, learn about AWS' edge infrastructure and solutions for HCLS sector, AWS Outposts, and an example use case.

Chief Digital Officer Bertrand Bodson shares why Novartis is excited to partner with AWS to transform our business operations.

Explore how Deloitte's MyPath uses AWS to enable decentralized clinical trials at scale.

Adapt your engagement strategy to overcome remote care challenges to accelerate recruitment, improve trial retention, and diversify participation.

AbCellera used its AI-powered technology platform to bring the world’s first COVID-19 antibody drug candidate into human clinical trials just months after its first screen of a patient blood sample.